![]() ![]() Curtis is an endowed professor of medicine and genetics at Stanford University, where she leads the Cancer Computational and Systems Biology group and serves as the director of Breast Cancer Translational Research and co-director of the Molecular Tumor Board at the Stanford Cancer Institute.Ĭhris Riback: Dr. Curtis and her team are specifically looking to develop more effective treatments for patients with metastatic estrogen receptor-positive breast cancer-and to develop novel ways to prevent recurrence in people with this form who are at a high risk of recurrence.Ī BCRF investigator since 2011, Dr. Christina Curtis and her colleagues are working to uncover. Why recurrence and metastasis happen and how we might then personalize breast cancer care and prediction is what Dr. To end deaths from breast cancer, we need to better understand both processes: recurrence (when breast cancer comes back) and metastasis (when it spreads to other areas of the body beyond the breast and lymph nodes). ![]() About 30 percent of people diagnosed with early-stage breast cancer will experience a recurrence and develop metastatic disease.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |